Literature DB >> 24555960

Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains.

Priya Palta1, Andrea L C Schneider1, Geert Jan Biessels2, Pegah Touradji3, Felicia Hill-Briggs4.   

Abstract

The objectives were to conduct a meta-analysis in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards to determine effect sizes (Cohen's d) for cognitive dysfunction in adults with type 2 diabetes, relative to nondiabetic controls, and to obtain effect sizes for the most commonly reported neuropsychological tests within domains. Twenty-four studies, totaling 26,137 patients (n = 3351 with diabetes), met study inclusion criteria. Small to moderate effect sizes were obtained for five of six domains: motor function (3 studies, n = 2374; d = -0.36), executive function (12 studies, n = 1784; d = -0.33), processing speed (16 studies, n = 3076; d = -0.33), verbal memory (15 studies, n = 4,608; d = -0.28), and visual memory (6 studies, n = 1754; d = -0.26). Effect size was smallest for attention/concentration (14 studies, n = 23,143; d = -0.19). The following tests demonstrated the most notable performance decrements in diabetes samples: Grooved Pegboard (dominant hand) (d = -0.60), Rey Auditory Verbal Learning Test (immediate) (d = -0.40), Trails B (d = -0.39), Rey-Osterreith Complex Figure (delayed) (d = -0.38), Trails A (d = -0.34), and Stroop Part I (d = -0.28). This study provides effect sizes to power future epidemiological and clinical diabetes research studies examining cognitive function and to help inform the selection of neuropsychological tests.

Entities:  

Mesh:

Year:  2014        PMID: 24555960      PMCID: PMC4132660          DOI: 10.1017/S1355617713001483

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  56 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

3.  Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement.

Authors:  Sherita Hill Golden; Arleen Brown; Jane A Cauley; Marshall H Chin; Tiffany L Gary-Webb; Catherine Kim; Julie Ann Sosa; Anne E Sumner; Blair Anton
Journal:  J Clin Endocrinol Metab       Date:  2012-06-22       Impact factor: 5.958

4.  A biethnic community survey of cognition in participants with type 2 diabetes, impaired glucose tolerance, and normal glucose tolerance: the New Mexico Elder Health Survey.

Authors:  R D Lindeman; L J Romero; A LaRue; C L Yau; D S Schade; K M Koehler; R N Baumgartner; P J Garry
Journal:  Diabetes Care       Date:  2001-09       Impact factor: 19.112

Review 5.  Diabetes and cognitive dysfunction.

Authors:  Rory J McCrimmon; Christopher M Ryan; Brian M Frier
Journal:  Lancet       Date:  2012-06-09       Impact factor: 79.321

Review 6.  Cognitive dysfunction in patients with type 2 diabetes.

Authors:  Yael D Reijmer; Esther van den Berg; Carla Ruis; L Jaap Kappelle; Geert Jan Biessels
Journal:  Diabetes Metab Res Rev       Date:  2010-10       Impact factor: 4.876

7.  Assessment practices of clinical neuropsychologists in the United States and Canada: a survey of INS, NAN, and APA Division 40 members.

Authors:  Laura A Rabin; William B Barr; Leslie A Burton
Journal:  Arch Clin Neuropsychol       Date:  2005-01       Impact factor: 2.813

8.  Type 2 diabetes mellitus, cognition and brain in aging: A brief review.

Authors:  Rajeev Kumar; Jeffrey C L Looi; Beverley Raphael
Journal:  Indian J Psychiatry       Date:  2009-01       Impact factor: 1.759

9.  Type II diabetes in mild cognitive impairment and Alzheimer's disease: results from a prospective population-based study in Germany.

Authors:  Pablo Toro; Peter Schönknecht; Johannes Schröder
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Association of type 2 diabetes with depression, brain atrophy, and reduced fine motor speed in a 60- to 64-year-old community sample.

Authors:  Rajeev Kumar; Kaarin J Anstey; Nicolas Cherbuin; Wei Wen; Perminder S Sachdev
Journal:  Am J Geriatr Psychiatry       Date:  2008-12       Impact factor: 4.105

View more
  80 in total

1.  Humans with Type-2 Diabetes Show Abnormal Long-Term Potentiation-Like Cortical Plasticity Associated with Verbal Learning Deficits.

Authors:  Peter J Fried; Lukas Schilberg; Anna-Katharine Brem; Sadhvi Saxena; Bonnie Wong; Aaron M Cypess; Edward S Horton; Alvaro Pascual-Leone
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 2.  Cerebrovascular complications of diabetes: focus on cognitive dysfunction.

Authors:  Trevor Hardigan; Rebecca Ward; Adviye Ergul
Journal:  Clin Sci (Lond)       Date:  2016-10-01       Impact factor: 6.124

3.  Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial.

Authors:  Malin Nilsson; Nicole Jensen; Michael Gejl; Marianne L Bergmann; Heidi Storgaard; Mette Zander; Kamilla Miskowiak; Jørgen Rungby
Journal:  Diabetologia       Date:  2019-07-31       Impact factor: 10.122

Review 4.  Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications.

Authors:  Geert Jan Biessels; Florin Despa
Journal:  Nat Rev Endocrinol       Date:  2018-10       Impact factor: 43.330

Review 5.  Diabetes and Cognitive Impairment.

Authors:  Lindsay A Zilliox; Krish Chadrasekaran; Justin Y Kwan; James W Russell
Journal:  Curr Diab Rep       Date:  2016-09       Impact factor: 4.810

Review 6.  Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer's disease in T2DM patients.

Authors:  Sebastian Bertram; Klara Brixius; Christian Brinkmann
Journal:  Endocrine       Date:  2016-05-09       Impact factor: 3.633

7.  Associations between recent severe hypoglycemia, retinal vessel diameters, and cognition in adults with type 1 diabetes.

Authors:  Christopher M Ryan; Barbara E K Klein; Kristine E Lee; Karen J Cruickshanks; Ronald Klein
Journal:  J Diabetes Complications       Date:  2016-08-14       Impact factor: 2.852

8.  Neurocognitive impairment in type 2 diabetes: evidence for shared genetic aetiology.

Authors:  Josephine Mollon; Joanne E Curran; Samuel R Mathias; Emma E M Knowles; Phoebe Carlisle; Peter T Fox; Rene L Olvera; Harald H H Göring; Amanda Rodrigue; Laura Almasy; Ravi Duggirala; John Blangero; David C Glahn
Journal:  Diabetologia       Date:  2020-02-04       Impact factor: 10.122

9.  Type 2 diabetes and cognitive decline over 14 years in middle-aged African Americans and whites: the ARIC Brain MRI Study.

Authors:  Elizabeth R Mayeda; Mary N Haan; John Neuhaus; Kristine Yaffe; David S Knopman; A Richey Sharrett; Michael E Griswold; Thomas H Mosley
Journal:  Neuroepidemiology       Date:  2014-11-13       Impact factor: 3.282

Review 10.  Hippocampal insulin resistance and cognitive dysfunction.

Authors:  Geert Jan Biessels; Lawrence P Reagan
Journal:  Nat Rev Neurosci       Date:  2015-10-14       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.